Alejandra Meaney

412 total citations
22 papers, 299 citations indexed

About

Alejandra Meaney is a scholar working on Endocrinology, Diabetes and Metabolism, General Health Professions and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Alejandra Meaney has authored 22 papers receiving a total of 299 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Endocrinology, Diabetes and Metabolism, 8 papers in General Health Professions and 7 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Alejandra Meaney's work include Diabetes, Cardiovascular Risks, and Lipoproteins (9 papers), Health and Lifestyle Studies (8 papers) and Obesity, Physical Activity, Diet (5 papers). Alejandra Meaney is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (9 papers), Health and Lifestyle Studies (8 papers) and Obesity, Physical Activity, Diet (5 papers). Alejandra Meaney collaborates with scholars based in Mexico, Honduras and Cuba. Alejandra Meaney's co-authors include Eduardo Meaney, Guillermo Ceballos, Juan Asbún, J J Hicks, Ivonne María Olivares-Corichi, Virginia Corina Samaniego, Israel Ramírez‐Sánchez, Gabriela Gutiérrez-Salmeán, Martín Guzmán and Nayelli Nájera and has published in prestigious journals such as SHILAP Revista de lepidopterología, American Journal of Physiology-Cell Physiology and European Journal of Pharmacology.

In The Last Decade

Alejandra Meaney

22 papers receiving 290 citations

Peers

Alejandra Meaney
K Krueger United States
Aled Roberts United Kingdom
Kirsten A. Berk Netherlands
Mohammad Saleem United States
Runyu Ye China
Rui Póvoa Brazil
Sagar S Makanji United States
K Krueger United States
Alejandra Meaney
Citations per year, relative to Alejandra Meaney Alejandra Meaney (= 1×) peers K Krueger

Countries citing papers authored by Alejandra Meaney

Since Specialization
Citations

This map shows the geographic impact of Alejandra Meaney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alejandra Meaney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alejandra Meaney more than expected).

Fields of papers citing papers by Alejandra Meaney

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alejandra Meaney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alejandra Meaney. The network helps show where Alejandra Meaney may publish in the future.

Co-authorship network of co-authors of Alejandra Meaney

This figure shows the co-authorship network connecting the top 25 collaborators of Alejandra Meaney. A scholar is included among the top collaborators of Alejandra Meaney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alejandra Meaney. Alejandra Meaney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Meaney, Alejandra, et al.. (2024). En busca de una escala de riesgo adecuada para los mexicanos. Las insuficiencias de la escala Globorisk. 35(1). 6–15. 1 indexed citations
2.
Meaney, Eduardo, et al.. (2024). Overweight, Obesity, and Age Are the Main Determinants of Cardiovascular Risk Aggregation in the Current Mexican Population: The FRIMEX III Study. Journal of Clinical Medicine. 13(8). 2248–2248. 1 indexed citations
3.
Meaney, Eduardo & Alejandra Meaney. (2023). Semántica conceptual, etnias, demónimos, lenguaje científico y corrección política. 34(1). 4–7. 1 indexed citations
4.
Meaney, Alejandra, et al.. (2023). The TG/HDL-c Lipid Ratio as a Cardiovascular Risk Marker in a Mexican Urban Middle-Class Population: Do We Need a Risk Score Tailored for Mexicans?. Journal of Clinical Medicine. 12(18). 6005–6005. 6 indexed citations
5.
Meaney, Alejandra, et al.. (2016). Metformin enhances left ventricular function in patients with metabolic syndrome. 27(1). 16–25. 5 indexed citations
6.
Meaney, Alejandra, et al.. (2016). Is Local Nitric Oxide Availability Responsible for Myocardial Salvage after Remote Preconditioning?. Arquivos Brasileiros de Cardiologia. 107(2). 154–62. 8 indexed citations
7.
Gutiérrez-Salmeán, Gabriela, Virginia Corina Samaniego, Alejandra Meaney, et al.. (2015). OBESITY PHENOTYPES IN URBAN MIDDLE-CLASS COHORTS; THE PRIT-LINDAVISTA MERGING EVIDENCE IN MEXICO: THE OPUS PRIME STUDY.. PubMed. 32(1). 182–8. 12 indexed citations
8.
Gutiérrez-Salmeán, Gabriela, Alejandra Meaney, Israel Ramírez‐Sánchez, et al.. (2014). Anthropometric traits, blood pressure, and dietary and physical exercise habits in health sciences students; the obesity observatory project.. SHILAP Revista de lepidopterología. 28(1). 194–201. 14 indexed citations
9.
Meaney, Alejandra, Guillermo Ceballos, Gabriela Gutiérrez-Salmeán, et al.. (2013). Cardiovascular risk factors in a Mexican middle-class urban population. The Lindavista Study. Baseline data. Archivos de cardiología de México. 83(4). 249–256. 20 indexed citations
10.
Rubio‐Gayosso, Ivan, Israel Ramírez‐Sánchez, Gabriela Gutiérrez-Salmeán, et al.. (2012). Testosterone metabolites mediate its effects on myocardial damage induced by ischemia/reperfusion in male Wistar rats. Steroids. 78(3). 362–369. 15 indexed citations
11.
Meaney, Eduardo, Alejandra Meaney, Israel Ramírez‐Sánchez, et al.. (2012). Does Metformin Increase Paraoxonase Activity in Patients with the Metabolic Syndrome? Additional Data from the MEFISTO Study. Clinical and Translational Science. 5(3). 265–268. 11 indexed citations
12.
Meaney, Alejandra, et al.. (2009). Alcance de metas cardiometabólicas en pacientes de alto riesgo en un hospital de tercer nivel. 20(3). 109–115. 1 indexed citations
13.
Meaney, Alejandra, et al.. (2009). The Vytorin on Carotid Intima‐Media Thickness and Overall Arterial Rigidity (VYCTOR) Study. The Journal of Clinical Pharmacology. 49(7). 838–847. 56 indexed citations
14.
Meaney, Eduardo, Virginia Corina Samaniego, Alejandra Meaney, et al.. (2008). METFORMIN, ARTERIAL FUNCTION, INTIMA–MEDIA THICKNESS AND NITROXIDATION IN METABOLIC SYNDROME: THE MEFISTO STUDY. Clinical and Experimental Pharmacology and Physiology. 35(8). 895–903. 70 indexed citations
15.
Rubio‐Gayosso, Ivan, Israel Ramírez, Eduardo Meaney, et al.. (2008). Intraluminal-restricted 17β-estradiol exerts the same myocardial protection against ischemia/reperfusion injury in vivo as free 17β-estradiol. Steroids. 73(5). 528–538. 8 indexed citations
16.
Esqueda, Agustín Lara, et al.. (2007). Factores de riesgo cardiovascular en población femenina urbana de México. El estudio FRIMEX IIa. 18(1). 24–34. 6 indexed citations
17.
Meaney, Eduardo, Agustín Lara‐Esqueda, Guillermo Ceballos, et al.. (2007). Cardiovascular risk factors in the urban Mexican population: The FRIMEX study. Public Health. 121(5). 378–384. 30 indexed citations
18.
Méndez-Bolaina, Enrique, Javier Sánchez‐Gonzalez, Israel Ramírez‐Sánchez, et al.. (2007). Effect of caveolin-1 scaffolding peptide and 17β-estradiol on intracellular Ca2+kinetics evoked by angiotensin II in human vascular smooth muscle cells. American Journal of Physiology-Cell Physiology. 293(6). C1953–C1961. 11 indexed citations
19.
Méndez, Enrique, Carlos Castillo, Israel Ramírez, et al.. (2006). Differential expression of α1-adrenergic receptor subtypes in coronary microvascular endothelial cells in culture. European Journal of Pharmacology. 546(1-3). 127–133. 12 indexed citations
20.
Martínez, Yolanda, Sonia Martı́nez, Alejandra Meaney, Eduardo Meaney, & Bruno Escalante. (2002). Angiotensin II Type 1 Receptor Blockade Restores Nitric Oxide–Dependent Renal Vascular Responses in Renovascular Hypertension. Journal of Cardiovascular Pharmacology. 40(3). 381–387. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026